Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,519 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy.
Bachireddy P, Azizi E, Burdziak C, Nguyen VN, Ennis CS, Maurer K, Park CY, Choo ZN, Li S, Gohil SH, Ruthen NG, Ge Z, Keskin DB, Cieri N, Livak KJ, Kim HT, Neuberg DS, Soiffer RJ, Ritz J, Alyea EP, Pe'er D, Wu CJ. Bachireddy P, et al. Among authors: kim ht. Cell Rep. 2023 Aug 29;42(8):113011. doi: 10.1016/j.celrep.2023.113011. Epub 2023 Aug 8. Cell Rep. 2023. PMID: 37556329 Free PMC article. No abstract available.
Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Alyea EP, Li S, Kim HT, Cutler C, Ho V, Soiffer RJ, Antin JH. Alyea EP, et al. Among authors: kim ht. Biol Blood Marrow Transplant. 2008 Aug;14(8):920-6. doi: 10.1016/j.bbmt.2008.05.024. Biol Blood Marrow Transplant. 2008. PMID: 18640576 Free PMC article. Clinical Trial.
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors.
Koreth J, Stevenson KE, Kim HT, Garcia M, Ho VT, Armand P, Cutler C, Ritz J, Antin JH, Soiffer RJ, Alyea EP 3rd. Koreth J, et al. Among authors: kim ht. Blood. 2009 Oct 29;114(18):3956-9. doi: 10.1182/blood-2009-07-231092. Epub 2009 Aug 27. Blood. 2009. PMID: 19713456 Free PMC article. Clinical Trial.
Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age.
Koreth J, Aldridge J, Kim HT, Alyea EP 3rd, Cutler C, Armand P, Ritz J, Antin JH, Soiffer RJ, Ho VT. Koreth J, et al. Among authors: kim ht. Biol Blood Marrow Transplant. 2010 Jun;16(6):792-800. doi: 10.1016/j.bbmt.2009.12.537. Epub 2010 Jan 13. Biol Blood Marrow Transplant. 2010. PMID: 20074656 Free PMC article.
1,519 results